Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: Sequential tamoxifen-exemestane and upfront anastrozole

C. Skedgel; D. Rayson; R. Dewar; T. Younis

doi:10.1007/s10549-006-9299-4

Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: Sequential tamoxifen-exemestane and upfront anastrozole

C. Skedgel, D. Rayson, R. Dewar, T. Younis

科研成果: 期刊稿件 › 文章 › 同行评审

源语言	英语
页（从-至）	325-333
页数	9
期刊	Breast Cancer Research and Treatment
卷	101
期	3
DOI	https://doi.org/10.1007/s10549-006-9299-4
出版状态	已出版 - 3月 2007

!!!ASJC Scopus Subject Areas

肿瘤学
癌症研究

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1007/s10549-006-9299-4

其它文件与链接

引用此

@article{d59fd99fdaf44fd88afb2571cc9db5f9,

title = "Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: Sequential tamoxifen-exemestane and upfront anastrozole",

author = "C. Skedgel and D. Rayson and R. Dewar and T. Younis",

note = "Funding Information: This evaluation was funded by a grant from the Capital Health Research Fund. A subsequent project adapted the model framework for an evaluation from the Belgian perspective with the support of Pfizer Belgium.",

year = "2007",

month = mar,

doi = "10.1007/s10549-006-9299-4",

language = "English",

volume = "101",

pages = "325--333",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York",

number = "3",

}

TY - JOUR

T1 - Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women

T2 - Sequential tamoxifen-exemestane and upfront anastrozole

AU - Skedgel, C.

AU - Rayson, D.

AU - Dewar, R.

AU - Younis, T.

N1 - Funding Information: This evaluation was funded by a grant from the Capital Health Research Fund. A subsequent project adapted the model framework for an evaluation from the Belgian perspective with the support of Pfizer Belgium.

PY - 2007/3

Y1 - 2007/3

UR - http://www.scopus.com/inward/record.url?scp=33846475483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846475483&partnerID=8YFLogxK

U2 - 10.1007/s10549-006-9299-4

DO - 10.1007/s10549-006-9299-4

M3 - Article

C2 - 16897433

AN - SCOPUS:33846475483

SN - 0167-6806

VL - 101

SP - 325

EP - 333

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 3

ER -

Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: Sequential tamoxifen-exemestane and upfront anastrozole

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此